Home
The Series
The Host
Past Shows
Board of Advisors
Guest Links
News Releases
Video Library
   
   
   
 


 
 

  Journal of Longevity
no identifiable risk
EARYL DETECTION, NEW TREAMENTS BRING HOPE

 

A mammogram revealed cancer in Bree's breast at 44.
Despite her medical background, she believes
the diagnosis impacted her like any
other woman.

by Heather Johnson Durocher

facing cancer risk  informed and empowered
When I speak to audiences about my breast cancer experience, I tell them that I was a "tree-hugging,
granola-crunching, exercise-addicted, vegetarian health-nut, who didn't drink or smoke" when I was
diagnosed at age 33. I didn't have a strong family history of cancer. My doctors implied that my cancer was a "fluke".
Yet there were red flags in my medical records, hints that might have alerted a health care team better educated in cancer genetics that my cancer might be hereditary. I learned about the existence of genetic testing for hereditary cancer not from my doctors, but from a magazine article. I also discovered that I fit the criteria for a possible hereditary cancer syndrome. I chose to pursue genetic counseling and genetic testing and learned that I carry a BRCA2 mutation which predisposed me to cancer.
Why does it matter if cancer is hereditary? For those who have already had cancer, genetic testing can affect treatment recommendations. It means there is a high risk for further breast cancer and for ovarian cancer. It also means that blood relatives may carry the mutation. A positive genetic test enables adult relatives who haven't had cancer to determine if they inherited the same cancer predisposition. The lifetime cancer risk that accompanies a hereditary predisposition is much higher than the risk in the general population. Additionally, hereditary cancers tend to be younger onset, when women are less likely to be screened and doctors are less likely to take their symptoms seriously.
There is the mistaken impression that nothing can be done if you have an increased risk for cancer, or that the options available are too drastic to consider. In reality there are several risk-management options, including surveillance programs specifically designed for high-risk women. These options sometimes involve making serious and deeply personal decisions. These decisions need to be based on solid information from experts specially trained in cancer genetics, not on myth or misinformation.
Genetic testing and its aftermath came with a need to connect with others who understood my situation. The issues were no worse than those I faced with my cancer diagnosis, just different. I found the lack of support and credible information isolating. To assure that no one else would have to face these issues alone, I started FORCE: Facing Our Risk of Cancer Empowered, (http://www.facingourrisk.org) an organization devoted to families affected by hereditary breast and ovarian cancer.


 

"The news was no less than the feeling of a truck hitting me in the stomach," says Bree, who is now in her 50s and requested that her full name not be used. "1 have no family history of breast cancer and the only possible known predisposition was my never having had children."
Bree's fight against the disease involved a lumpectomy, six months of chemotherapy, seven weeks of radiation and five years of tamoxifen, an anti-estrogen drug, FDA-approved for risk reduction. Now breast-cancer free, Bree says a positive attitude also played a critical role in her survival.
" I never let any fear run rampant. 1 faced it all head on," she says.

Surviving Cancer
Bree is among more than 2 million breast cancer survivors in the United States today, according to the National Alliance of Breast Cancer Organizations in New York, NY. As scary as this disease is - one out of nine women will develop breast cancer in her lifetime and nearly 40,000 women are expected to die of the disease in 2003 - experts say more and more cases of early detection coupled with new treatment options provide much hope for battling this disease.
Today, only six percent of breast cancers are diagnosed at advanced or metastatic stage (the spread of cancer from its original site) when the five-year survival rate is 23 percent, according to the National Alliance of Breast Cancer Organizations. Treatment options, meanwhile, continue to grow in scope, experts say.
" There has been a tremendous increase in the variety of treatments of breast cancer," says Dr. Elizabeth Ann Shaughnessy, a surgical oncologist specializing in breast disease at the University of Cincinnati Department of Surgery. "It's probably one of the most treatable cancers there is today. Our abilities to help people live with their cancers are so good that you look at a cancer that is stage four (terminal) and there are people living six to 10 years out from their diagnosis. That certainly wasn't the norm 20 to 30 years ago."
This is encouraging news for women like Marcella Hinkel, 41, whose cancer has spread from her breast to her liver and bones. Hinkel, who received her breast-cancer diagnosis at age 35 after a self-exam revealed a lump, thought she had beaten the disease after going through a lumpectomy, chemotherapy and radiation. She also took the drug tamoxifen for five years.
" 1 started having pain in my upper right abdomen for about a year before I was diagnosed with the metastasis to my liver," says the Baltimore, Md., mother of a 7 -year-old son.

Risk factors
This year, 211,300 new cases of female invasive breast cancer - cancer that has spread to nearby tissue, lymph nodes under the arm, or other parts of the body - and 55,700 cases of noninvasive cancer will be diagnosed, according to the National Alliance of Breast Cancer Organizations.
Some 77 percent of new breast-cancer cases each year occur in women age 50 and older, with the average age of diagnosis being 62 years old, says Elizabeth Woolfe, director of information services for the National Alliance of Breast Cancer Organizations.
Breast cancer runs in Hinkel's family her sister, now in remission, was diagnosed in 1999. If a family history is present, it's the greatest influence on a woman with a breast cancer diagnosis, Dr. Shaughnessy says. Still, the majority of breast cancer cases occur in women who have no identifiable risk factors.
Hormone replacement therapy in post-menopausal women has shown to increase a woman's risk for developing breast cancer, Dr. Shaughnessy says. The age a woman is when she has her first period as well as when she has babies also play roles.
" Women who get pregnant before age 30 whose age at menarche is 12 or after, and women whose age at menopause is 50 to 52 or before, actually have a lower risk," she says.
" Women never pregnant or pregnant after 35 have a higher risk. It's not absolutely clear, but the hormones continuously cycling appear to playa role. There's probably some other factors present that we don't fully understand."
Other risk factors, according to NABCO, include:
•Not having children or having a first child after age 30.
•Radiation therapy (RT) to the chest or upper body to treat Hodgkin's
•Disease, thyroid conditions or cancer.
•A history of previous breast biopsies and benign (not cancerous) breast disease with certain findings.
•Being overweight or obese after menopause. Maintaining a healthy weight and losing excess weight lowers a woman's risk of breast cancer compared to overweight women. It's important to maintain a diet low in fat, exercise regularly and avoid alcohol and smoking.

Fighting Back
If detected early, breast cancer can be treated effectively with surgery that preserves the breast, followed by radiation therapy This local therapy is often accompanied by chemotherapy and/or hormonal therapy Currently, 63 percent of breast cancers are discovered at an early, "localized" stage, and five-year survival after treatment for early-stage breast cancer is 97 percent, according to NABCO.
In addition to medical treatment, which varies from woman to woman depending upon the breast cancer stage and the route she and her healthcare provider deem most appropriate for her disease, positive attitudes make a huge difference, say those personally touched by the disease.
During treatment, which left her feeling fatigued, Bree paced her work. She also went into what she called "a fierce survivor mode."
" All small situations became very unimportant. I concentrated on my wellness - emotional, physical, spiritual," she says.
Despite having metastasis, Hinkel remains optimistic today: "Once you are diagnosed with a cancer that has spread, you are automatically considered Stage 4, which means terminal," she says. "But I don't plan on going anywhere."
Support from loved ones, whether in the form of family and friends or support groups if a woman is comfortable in these settings, also is key, Dr. Shaughnessy says.
Adds Bree, "A diagnosis of breast cancer is not a death sentence."




About the Author: Heather Johnson Durocher is a senior contributing writer for Women's Health & Fitness and iParenting.com.